Neurocognitive functioning in schizophrenia and bipolar disorder: Clarifying concepts of diagnostic dichotomy vs. continuum

Frontiers in Psychiatry

Volumn 4, Issue DEC, 2013, Pages

  Kuswanto, Carissa N ^a   Sum, Min Y ^a   Sim, Kang ^a  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

Author keywords

Bipolar disorder; Kraepelinian dichotomy; Neurocognitive functions; Psychosocial functioning; Psychotic spectrum; Schizophrenia

Indexed keywords

CHLORPROMAZINE;

ADULT; ARTICLE; BIPOLAR DISORDER; BRIEF ASSESSMENT OF COGNITION BATTERY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; NEUROCOGNITION; NEUROCOGNITIVE FUNCTIONING; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOMETRY; RIGHT HANDEDNESS; SCHIZOPHRENIA; SEMANTIC MEMORY; SOCIAL PSYCHOLOGY; TASK PERFORMANCE; VERBAL MEMORY; WORKING MEMORY; YOUNG MANIA RATING SCALE;

EID: 84891710405     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2013.00162     Document Type: Article

References (63)

1. Möller HJ. Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond. Eur Arch Psychiatry Clin Neurosci (2008) 258(Suppl 2):48-73. doi:10.1007/s00406-008-2004-3.
2. Sorias S. Is the neo-Kraepelinian paradigm in a phase of crisis? Turk Psikiyatri Derg (2012) 23:117-29.
3. Berrios GE, Beer D. The notion of a unitary psychosis: a conceptual history. Hist Psychiatry (1994) 5:13-36. doi:10.1177/0957154X9400501702.
4. Kraepelin E. Dementia Praecox and Paraphenia. Edinburg: Livingstone (1919).
5. Bellivier F, Geoffroy PA, Scott J, Schurhoff F, Leboyer M, Etain B. Biomarkers of bipolar disorder: specific or shared with schizophrenia? Front Biosci (Elite Ed) (2013) E5:845-63. doi:10.2741/E665.
6. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res (2004) 71:405-16. doi:10.1016/j.schres.2004.03.002.
7. Yu K, Cheung C, Leung M, Li Q, Chua S, McAlonan G. Are bipolar disorder and schizophrenia neuroanatomically distinct? An anatomical likelihood meta-analysis. Front Hum Neurosci (2010) 4:189. doi:10.3389/fnhum.2010.00189.
8. Demjaha A, MacCabe JH, Murray RM. How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophr Bull (2012) 38:209-14. doi:10.1093/schbul/sbr100.
9. Fusar-Poli P, Deste G, Smieskova R, Barlati S, Yung AR, Howes O, et al. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry (2012) 69:562-71. doi:10.1001/archgenpsychiatry.2011.1592.
10. Lewandowski KE, Cohen BM, Öngur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med (2011) 41:225-41. doi:10.1017/S0033291710001042.
11. Napal O, Ojeda N, Sánchez P, Elizagárate E, Peña J, Ezcurra J, et al. The course of the schizophrenia and its impact on cognition: a review of literature. Actas Esp Psiquiatr (2012) 40:198-220.
12. O'Donnell BF. Cognitive impairment in schizophrenia: a life span perspective. Am J Alzheimers Dis Other Demen (2007) 22:398-405. doi:10.1177/1533317507304745.
13. Young RC, Murphy CF, Heo M, Schulberg HC, Alexopoulos GS. Cognitive impairment in bipolar disorder in old age: literature review and findings in manic patients. J Affect Disord (2006) 92:125-31. doi:10.1016/j.jad.2005.12.042.
14. Depp CA, Moore DJ, Sitzer D, Palmer BW, Eyler LT, Roesch S, et al. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. J Affect Disord (2007) 101:201-9. doi:10.1016/j.jad.2006.11.022.
15. Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res (2010) 117:1-12. doi:10.1016/j.schres.2009.12.022.
16. Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res (2005) 80:137-49. doi:10.1016/j.schres.2005.08.004.
17. Schretlen DJ, Cascella NG, Meyer SM, Kingery LR, Testa SM, Munro CA, et al. Neuropsychological functioning in bipolar disorder and schizophrenia. Biol Psychiatry (2007) 62:179-86. doi:10.1016/j.biopsych.2006.09.025.
18. Seidman LJ, Kremen WS, Koren D, Faraone SV, Goldstein JM, Tsuang MT. A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophr Res (2002) 53:31-44. doi:10.1016/S0920-9964(01)00162-1.
19. Craddock N, Owen MJ. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry (2005) 186:364-6. doi:10.1192/bjp.186.5.364.
20. Craddock N, Owen MJ. Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry (2007) 6:84-91.
21. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry (2009) 195:194-201. doi:10.1192/bjp.bp.108.059717.
22. De Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Des (2012) 18:486-94. doi:10.2174/138161212799316253.
23. Lee KW, Woon PS, Teo YY, Sim K. Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? Neurosci Biobehav Rev (2012) 36:556-71. doi:10.1016/j.neubiorev.2011.09.001.
24. Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, Carroll L, et al. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry (2011) 16:429-41. doi:10.1038/mp.2010.36.
25. Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry (2004) 56:560-9. doi:10.1016/j.biopsych.2004.08.002.
26. Daban C, Martinez-Aran A, Torrent C, Tabarés-Seisdedos R, Balanzá-Martinez V, Salazar-Fraile J, et al. Specificity of cognitive deficits in bipolar disorder versus schizophrenia. Psychother Psychosom (2006) 75:72-84. doi:10.1159/000090891.
27. Glahn DC, Bearden CE, Cakir S, Barrett JA, Najt P, Monkul ES, et al. Differential working memory impairment in bipolar disorder and schizophrenia: effect of lifetime history of psychosis. Bipolar Disord (2006) 8:117-23. doi:10.1111/j.1399-5618.2006.00296.x.
28. Meesters PD, Schouws S, Stek M, de Haan L, Smit J, Eikelenboom P, et al. Cognitive impairment in late life schizophrenia and bipolar I disorder. Int J Geriatr Psychiatry (2013) 28:82-90. doi:10.1002/gps.3793.
29. Sánchez-Morla EM, Barabash A, Martínez-Vizcaíno V, Tabarés-Seisdedos R, Balanzá-Martínez V, Gabranes-Díaz JA, et al. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenia patients. Psychiatry Res (2009) 169:220-8. doi:10.1016/j.psychres.2008.06.032.
30. Simonsen C, Sundet K, Vaskinn A, Birkenaes AB, Engh JA, Færden A, et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr Bull (2011) 37:73-83. doi:10.1093/schbul/sbp034.
31. Varga M, Magnusson A, Flekkøy K, David AS, Opjordsmoen S. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter? Compr Psychiatry (2007) 48:583-91. doi:10.1016/j.comppsych.2007.06.003.
32. Bora E, Yucel M, Fornito A, Berk M, Pantelis C. Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers. Acta Psychiatr Scand (2008) 118:172-87. doi:10.1111/j.1600-0447.2008.01230.x.
33. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Version. (SCID-P). Washington, DC: American Psychiatric Press (1994).
34. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-non-Patient Version. (SCID-P). Washington, DC: American Psychiatric Press (2002).
35. Keefe RSE, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res (2004) 68:283-97. doi:10.1016/j.schres.2003.09.011.
36. Ueoka Y, Tomotake M, Tanaka T, Kaneda Y, Taniguchi K, Nakataki M, et al. Quality of life and cognitive dysfunction in people with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2011) 35:53-9. doi:10.1016/j.pnpbp.2010.08.018.
37. Stone MH, Jastak S, Wilkinson G. Wide Range Achievement Test. New York: Harcourt Assessment (1995).
38. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association (2000).
39. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 13:261-76. doi:10.1093/schbul/13.2.261.
40. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry (1978) 133:429-35. doi:10.1192/bjp.133.5.429.
41. Morice R. Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania. Br J Psychiatry (1990) 157:50-4. doi:10.1192/bjp.157.1.50.
42. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull (2006) 32:9-16. doi:10.1093/schbul/sbj033.
43. Goes FS, Hamshere ML, Seifuddin F, Pirooznia M, Belmonte-Mahon P, Breuer R, et al. Genome-wide association of mood-incongruent psychotic bipolar disorder. Transl Psychiatry (2012) 2:e180. doi:10.1038/tp.2012.106.
44. Lichenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet (2009) 373:234-9. doi:10.1016/S0140-6736(09)60072-6.
45. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 460:748-52. doi:10.1038/nature08185.
46. Andreassen OA, Thompson WK, Schork AJ, Ripke S, Mattingsdal M, Kelsoe JR, et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet (2013) 9:e1003455. doi:10.1371/journal.pgen.1003455.
47. Anderson D, Ardekani BA, Burdick KE, Robinson DG, John M, Malhotra AK, et al. Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder. Bipolar Disord (2013) 15:680-93. doi:10.1111/bdi.12096.
48. McDonald C, Bullmore ET, Sham PC, Chitnis X, Wickham H, Bramon E, et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry (2004) 61:974-84. doi:10.1001/archpsyc.61.10.974.
49. Schuster C, Schuller AM, Paulos C, Namer I, Pull C, Danion JM, et al. Gray matter volume decreases in elderly patients with schizophrenia: a voxel-based morphometry study. Schizophr Bull (2012) 38:796-802. doi:10.1093/schbul/sbq150.
50. Rajji TK, Voineskos AN, Butters MA, Miranda D, Arenovich T, Menon M, et al. Cognitive performance of individuals with schizophrenia across seven decades: a study using the MATRICS Consensus Cognitive Battery. Am J Geriatr Psychiatry (2013) 21:108-18. doi:10.1016/j.jagp.2012.10.011.
51. Smith MJ, Barch DM, Csernansky JG. Bridging the gap between schizophrenia and psychotic mood disorders: relating neurocognitive deficits to psychopathology. Schizophr Res (2009) 107:69-75. doi:10.1016/j.schres.2008.07.014.
52. Gildengers AG, Chisholm D, Butters MA, Anderson SJ, Begley A, Holm M, et al. Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression? Psychol Med (2013) 43:801-11. doi:10.1017/S0033291712001614.
53. Arts B, Jabben N, Krabbendam L, van Os J. A 2-year naturalistic study on cognitive function in bipolar disorder. Acta Psychiatr Scand (2011) 123:190-205. doi:10.1111/j.1600-0447.2010.01601.x.
54. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley bipolar disorder project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry (2004) 64:86-93. doi:10.4088/JCP.v64n0116.
55. Keefe RSE, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry (2007) 64:633-47. doi:10.1001/archpsyc.64.6.633.
56. Mishara AL, Goldberg TE. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol Psychiatry (2004) 55:1013-22. doi:10.1016/j.biopsych.2004.01.027.
57. Rossi A, Arduini L, Daneluzzo E, Bustini M, Prosperini P, Stratta P. Cognitive function in euthymic bipolar patients, stabilized schizophrenic patients, and healthy controls. J Psychiatr Res (2000) 34:333-9. doi:10.1016/S0022-3956(00)00025-X.
58. Pardo PJ, Knesevich MA, Vogler GP, Pardo JV, Twone B, Cloninger CR, et al. Genetic and state variables of neurocognitive dysfunction in schizophrenia: a twin study. Schizophr Bull (2000) 26:459-77. doi:10.1093/oxfordjournals.schbul.a033466.
59. Sobzcak S, Honig A, Schmitt JAJ, Riedel WJ. Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls. Neuropsychopharmacology (2003) 28:711-9. doi:10.1038/sj.npp.1300055.
60. Sarapas C, Shankman SA, Harrow M, Goldberg JF. Parsing trait and state effects of depression severity on neurocognition: evidence from a 26-year longitudinal study. J Abnorm Psychol (2012) 121:830-7. doi:10.1037/a0028141.
61. Gopal YV, Variend H. First-episode schizophrenia: review of cognitive deficits and cognitive remediation. Adv Psychiatr Treat (2005) 11:38-44. doi:10.1192/apt.11.1.38.
62. Serrani D. Neurocognitive assessment of ultra high risk of psychosis states using the MATRICS battery (measurement and treatment research to improve cognition in schizophrenia). Rev Psiq Clin (2011) 38:130-4. doi:10.1590/S0101-60832011000400003.
63. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V). Arlington, VA: American Psychiatric Publishing (2013).